Lovkesh Bhayana – Medorah Meditek Pvt Ltd

• Lovkesh Bhayana co-founded Medorah Meditek Pvt Ltd in July 2017, focusing on innovation in the healthcare sector through advanced medical technologies.
• Prior to Medorah Meditek, Lovkesh Bhayana co-founded DUKEN PHARMACEUTICALS in September 2015, contributing to the pharmaceutical industry with a commitment to quality and accessibility.
• At Medorah Meditek, significant milestones include the development of cutting-edge medical devices that enhance patient care and streamline healthcare processes.
• Lovkesh Bhayana has faced challenges in navigating regulatory landscapes and ensuring compliance for new medical technologies but has successfully established a robust framework for quality assurance.
• Under Lovkesh Bhayana's leadership, Medorah Meditek has built strategic partnerships with other healthcare providers and institutions, fostering collaboration and knowledge sharing.
• The ventures have contributed to job creation and have positively impacted local economies by driving innovation in healthcare solutions.
• Lovkesh Bhayana has emphasized sustainable practices within Medorah Meditek, showcasing a commitment to environmental responsibility in healthcare manufacturing.
• Through participation in industry conferences and events, Lovkesh Bhayana has raised awareness about the importance of technological advancements in healthcare, influencing peers and stakeholders.

Professional Experience

Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)

Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.

Official Email: Via Medorah Meditek Pvt Ltd corporate communication desk.

Personal Contact: Not publicly disclosed.

What is Lovkesh Bhayana's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).

How can I contact them?
Through Medorah Meditek Pvt Ltd's official communication channels.

Is this an official profile?
No — independently created using public data.

This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.

Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.

Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.

Affluense AI – Smarter Insights. Stronger Relationships with Affluents.

Last Updated: December 2025 · Published by Affluense AI (affluense.ai)